MabLab is building the first self-administered test to detect the five deadliest lacing agents in drugs and drinks — potentially saving more than one hundred thousand lives and preventing an additional five million hospitalizations every year. In response to one of our close peers who overdosed when taking laced drugs for the first time, we have made it our personal mission to deliver a harm reduction tool that will alert users about the presence of these dangerous additives. Our test delivers a result in under three minutes with unparalleled accuracy.
Together, let’s save lives with MabLab.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 127 Western Avenue,
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- http://mablab.tech
- Keywords
- startup, entrepreneurship, consumer, healthcare, life sciences, harvard, columbia, social impact, saving lives, overdose prevention.
- HQ
- Boston, MA
Mablab Questions
Mablab's website is http://mablab.tech
Mablab's LinkedIn profile is https://www.linkedin.com/company/mablabtests
Mablab has
7 employees.
View email and phone details for 7
employees at Mablab.
Mablab's industry is
Public Health
Mablab's top competitors are
Re.solution,
Intero Biosystems,
.406 Ventures,
Sideshift,
Gecko Materials,
Salva Health,
Stitch3d,
Pattern Materials Graphene,
Xatoms,
Saarey.
Mablab's categories are Public Health
Mablab's founding year is 2022
